Radioisotope generators for short-lived positron emitters applicable to positron emission tomography

Author(s):  
Y. Yano
2019 ◽  
Vol 64 (6) ◽  
pp. 70-81
Author(s):  
A. Khmelev

Introduction 1. General requirements to PET-radionuclides 2. Parameters of radionuclide ranging for application in PET 3. Positron emitters for different applications. Selection criteria - PET-studies - Joint PET- and SPECT-studies - Theranostics - Special applications 4. Availability of positron emitters - Cyclotron production of PET-radionuclides - Conventional radionuclides - Radionuclides under development - Production of PET-radionuclides on radionuclide generators 5. Future development of PET providing with radionuclides Conclusion


2005 ◽  
Vol 20 (1) ◽  
pp. 23-26 ◽  
Author(s):  
Joanne Beebe-Wang ◽  
Avraham Dilmanian ◽  
Stephen Peggs ◽  
David Schlyer ◽  
Paul Vaska

Proton therapy is a treatment modality of increasing utility in clinical radiation oncology mostly because its dose distribution conforms more tightly to the target volume than X-ray radiation therapy. One important feature of proton therapy is that it produces a small amount of positron-emitting isotopes along the beam-path through the non-elastic nuclear interaction of protons with target nuclei such as 12C, 14N, and 16O. These radio isotopes, mainly 11C, 13N, and 15O, al low imaging the therapy dose distribution using positron emission tomography. The resulting positron emission tomography images provide a powerful tool for quality assurance of the treatment, especially when treating inhomogeneous organs such as the lungs or the head-and-neck, where the calculation of the dose distribution for treatment planning is more difficult. This pa per uses Monte Carlo simulations to predict the yield of positron emitters produced by a 250 MeV proton beam, and to simulate the productions of the image in a clinical PET scanner.


2018 ◽  
Vol 52 ◽  
pp. 22
Author(s):  
Ikechi Ozoemelam ◽  
Emiel R. van der Graaf ◽  
Sytze Brandenburg ◽  
Peter Dendooven

2019 ◽  
Vol 64 (6) ◽  
pp. 82-87
Author(s):  
I. Znamenskiy ◽  
A. Kondakov ◽  
D. Mosin ◽  
P. Nikitin ◽  
A. Sozykin ◽  
...  

This review considers literature sources on myocardial perfusion studies using positron emission tomography with rubidium-82. The history of the development of the method, the protocols of the study, the dissymmetric data are analyzed, and comparisons are made with other positron emitters that are used in clinical practice and research to study myocardial blood supply. The use of PET/CT with rubidium-82 makes it possible to obtain valuable diagnostic information and it allows to measure myocardial blood directly and make a separate assessment of the coronary arteries function. Due to the fact that the production of rubidium-82 does not require an on-site cyclotron and a radiochemical laboratory, this method of imaging is more accessible than other positron emitters used for the same purpose. Also, the study is not associated with significant discomfort for the patient, since the full stress/rest imaging protocol requires less than half an hour. However, the use of rubidium-82 has a number of drawbacks, including the relatively low sharpness of the resulting image due to the high energy of the emitting positrons. Also there is a necessity for a mathematical correction of the roll-off phenomenon, which is a decrease in radiopharmaceutical extraction with an increase in myocardial blood flow. Due to the short half-life period, the provision of stress tests with ergometers is difficult. It needed to use pharmacological stress tests. In addition, usage of rubidium-82 is characterized by a high cost both due to the expensive production of the parent isotope, strontium-82, and the need for frequent replacement of generators – on average, 11 to 13 times a year.


1994 ◽  
Author(s):  
Bertha K. Madras ◽  
◽  
David R. Elmaleh ◽  
Peter C. Meltzer ◽  
Anna Y. Liung ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document